BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25370510)

  • 1. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.
    ; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith M; Sibony P; Plumb K; Wang JK; Werner JS
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8180-8. PubMed ID: 25370510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.
    ; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith MJ; Sibony P; Plumb K; Wang JK; Werner JS
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8173-9. PubMed ID: 25370513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.
    ;
    Ophthalmology; 2015 Sep; 122(9):1939-45.e2. PubMed ID: 26198807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optic Nerve Head Volumetry by Optical Coherence Tomography in Papilledema Related to Idiopathic Intracranial Hypertension.
    Dreesbach M; Joachimsen L; Küchlin S; Reich M; Gross NJ; Brandt AU; Schuchardt F; Harloff A; Böhringer D; Lagrèze WA
    Transl Vis Sci Technol; 2020 Feb; 9(3):24. PubMed ID: 32742754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeatability of peripapillary retinal nerve fiber layer and inner retinal thickness among two spectral domain optical coherence tomography devices.
    Matlach J; Wagner M; Malzahn U; Göbel W
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6536-46. PubMed ID: 25228545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated quantification of volumetric optic disc swelling in papilledema using spectral-domain optical coherence tomography.
    Wang JK; Kardon RH; Kupersmith MJ; Garvin MK
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4069-75. PubMed ID: 22599584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.
    Huang-Link YM; Al-Hawasi A; Oberwahrenbrock T; Jin YP
    Clin Neurol Neurosurg; 2015 Mar; 130():122-7. PubMed ID: 25614195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating mild papilledema and buried optic nerve head drusen using spectral domain optical coherence tomography.
    Kulkarni KM; Pasol J; Rosa PR; Lam BL
    Ophthalmology; 2014 Apr; 121(4):959-63. PubMed ID: 24321144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular ganglion cell layer imaging in preperimetric glaucoma with speckle noise-reduced spectral domain optical coherence tomography.
    Nakano N; Hangai M; Nakanishi H; Mori S; Nukada M; Kotera Y; Ikeda HO; Nakamura H; Nonaka A; Yoshimura N
    Ophthalmology; 2011 Dec; 118(12):2414-26. PubMed ID: 21924499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optic Nerve Head and Macular Optical Coherence Tomography Measurements in Papilledema Compared With Pseudopapilledema.
    Aghsaei Fard M; Okhravi S; Moghimi S; Subramanian PS
    J Neuroophthalmol; 2019 Mar; 39(1):28-34. PubMed ID: 29474199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography of the swollen optic nerve head: deformation of the peripapillary retinal pigment epithelium layer in papilledema.
    Kupersmith MJ; Sibony P; Mandel G; Durbin M; Kardon RH
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6558-64. PubMed ID: 21705690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal nerve fiber layer thickness analysis in cases of papilledema using optical coherence tomography – A case control study.
    Ahuja S; Anand D; Dutta TK; Roopesh Kumar VR; Kar SS
    Clin Neurol Neurosurg; 2015 Sep; 136():95-9. PubMed ID: 26093225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale.
    Scott CJ; Kardon RH; Lee AG; Frisén L; Wall M
    Arch Ophthalmol; 2010 Jun; 128(6):705-11. PubMed ID: 20547947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fibre layer thickness in idiopathic intracranial hypertension.
    Aojula A; Mollan SP; Horsburgh J; Yiangou A; Markey KA; Mitchell JL; Scotton WJ; Keane PA; Sinclair AJ
    BMC Ophthalmol; 2018 Jan; 17(1):257. PubMed ID: 29298687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Resolution Imaging of the Optic Nerve and Retina in Optic Nerve Hypoplasia.
    Pilat A; Sibley D; McLean RJ; Proudlock FA; Gottlob I
    Ophthalmology; 2015 Jul; 122(7):1330-9. PubMed ID: 25939636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Custom Optical Coherence Tomography Parameters for Distinguishing Papilledema from Pseudopapilledema.
    Pardon LP; Cheng H; Tang RA; Saenz R; Frishman LJ; Patel NB
    Optom Vis Sci; 2019 Aug; 96(8):599-608. PubMed ID: 31318797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation Between Optic Disc Peripapillary Capillary Network and Papilledema Grading in Patients With Idiopathic Intracranial Hypertension: A Study of Optical Coherence Tomography Angiography.
    Rodriguez Torres Y; Lee P; Mihlstin M; Tomsak RL
    J Neuroophthalmol; 2021 Mar; 41(1):48-53. PubMed ID: 31972713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganglion cell loss in relation to visual disability in multiple sclerosis.
    Walter SD; Ishikawa H; Galetta KM; Sakai RE; Feller DJ; Henderson SB; Wilson JA; Maguire MG; Galetta SL; Frohman E; Calabresi PA; Schuman JS; Balcer LJ
    Ophthalmology; 2012 Jun; 119(6):1250-7. PubMed ID: 22365058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional imaging of the macular retinal nerve fiber layer in glaucoma with spectral-domain optical coherence tomography.
    Sakamoto A; Hangai M; Nukada M; Nakanishi H; Mori S; Kotera Y; Inoue R; Yoshimura N
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5062-70. PubMed ID: 20463326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Spectral-Domain Optical Coherence Tomography in Differentiating Papilledema From Pseudopapilledema: A Prospective Longitudinal Study.
    Jivraj I; Cruz CA; Pistilli M; Kohli AA; Liu GT; Shindler KS; Avery RA; Garvin MK; Wang JK; Ross A; Tamhankar MA
    J Neuroophthalmol; 2021 Dec; 41(4):e509-e515. PubMed ID: 32956225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.